NASDAQ:MYGN - Myriad Genetics News Headlines

$24.76
+0.75 (+3.12 %)
(As of 06/18/2019 08:36 AM ET)
Today's Range
$23.81
Now: $24.76
$24.78
50-Day Range
$23.59
MA: $26.66
$34.57
52-Week Range
$23.08
Now: $24.76
$50.44
Volume757,200 shs
Average Volume975,965 shs
Market Capitalization$1.82 billion
P/E Ratio20.63
Dividend YieldN/A
Beta0.79

Headlines

Myriad Genetics (NASDAQ MYGN) News Headlines

Source:
DateHeadline
Rough session for Myriad as bear gets more bearishRough session for Myriad as bear gets more bearish
seekingalpha.com - June 14 at 3:34 PM
Myriad Genetics (NASDAQ:MYGN) Given New $20.00 Price Target at BarclaysMyriad Genetics (NASDAQ:MYGN) Given New $20.00 Price Target at Barclays
www.americanbankingnews.com - June 14 at 10:09 AM
Corporations Shouldn't Be Able to Patent Your DNACorporations Shouldn't Be Able to Patent Your DNA
finance.yahoo.com - June 12 at 2:22 PM
Myriad Genetics Target of Unusually Large Options Trading (NASDAQ:MYGN)Myriad Genetics Target of Unusually Large Options Trading (NASDAQ:MYGN)
www.americanbankingnews.com - June 11 at 6:56 AM
Why Is Myriad (MYGN) Down 6.4% Since Last Earnings Report?Why Is Myriad (MYGN) Down 6.4% Since Last Earnings Report?
finance.yahoo.com - June 6 at 10:28 AM
Myriad Genetics Announces Study Results Of myRisk Cancer TestMyriad Genetics Announces Study Results Of myRisk Cancer Test
finance.yahoo.com - June 5 at 3:35 PM
AngioDynamics Divests NAMIC Portfolio to Medline IndustriesAngioDynamics Divests NAMIC Portfolio to Medline Industries
finance.yahoo.com - June 5 at 3:35 PM
Myriad Genetics to Present at the 2019 Goldman Sachs Global Healthcare ConferenceMyriad Genetics to Present at the 2019 Goldman Sachs Global Healthcare Conference
finance.yahoo.com - June 5 at 8:48 AM
Heres Why Genetic Testing Stocks Lost as Much as 26.1% in MayHere's Why Genetic Testing Stocks Lost as Much as 26.1% in May
www.fool.com - June 4 at 3:29 PM
Here's Why Genetic Testing Stocks Lost as Much as 26.1% in MayHere's Why Genetic Testing Stocks Lost as Much as 26.1% in May
finance.yahoo.com - June 4 at 3:29 PM
Myriad Genetics Announces New Results from Two Large Studies of Its myRisk® Hereditary Cancer Test at American Society of Clinical OncologyMyriad Genetics Announces New Results from Two Large Studies of Its myRisk® Hereditary Cancer Test at American Society of Clinical Oncology
finance.yahoo.com - June 3 at 10:51 AM
Myriad Genetics' (MYGN) POLO Study Shows Positive ResultsMyriad Genetics' (MYGN) POLO Study Shows Positive Results
finance.yahoo.com - June 3 at 10:51 AM
BRACAnalysis CDx® Companion Diagnostic Test...BRACAnalysis CDx® Companion Diagnostic Test...
www.benzinga.com - June 2 at 3:27 PM
BRACAnalysis CDx® Companion Diagnostic Test Identifies Patients with Metastatic Pancreatic Cancer Who Benefited from Treatment with Lynparza® (olaparib)BRACAnalysis CDx® Companion Diagnostic Test Identifies Patients with Metastatic Pancreatic Cancer Who Benefited from Treatment with Lynparza® (olaparib)
finance.yahoo.com - June 2 at 9:38 AM
Is Myriad Genetics, Inc.'s (NASDAQ:MYGN) CEO Salary Justified?Is Myriad Genetics, Inc.'s (NASDAQ:MYGN) CEO Salary Justified?
finance.yahoo.com - May 30 at 9:49 AM
Financial Review: Fluoropharma Medical (FPMI) and Myriad Genetics (MYGN)Financial Review: Fluoropharma Medical (FPMI) and Myriad Genetics (MYGN)
www.americanbankingnews.com - May 28 at 12:13 PM
$221.45 Million in Sales Expected for Myriad Genetics, Inc. (MYGN) This Quarter$221.45 Million in Sales Expected for Myriad Genetics, Inc. (MYGN) This Quarter
www.americanbankingnews.com - May 28 at 1:08 AM
Myriad Genetics, Inc. (MYGN) Given Consensus Recommendation of "Hold" by BrokeragesMyriad Genetics, Inc. (MYGN) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - May 27 at 7:16 AM
Zacks: Brokerages Anticipate Myriad Genetics, Inc. (MYGN) Will Post Earnings of $0.47 Per ShareZacks: Brokerages Anticipate Myriad Genetics, Inc. (MYGN) Will Post Earnings of $0.47 Per Share
www.americanbankingnews.com - May 27 at 12:18 AM
Why Should You Hold on to Myriad Genetics (MYGN) Stock?Why Should You Hold on to Myriad Genetics (MYGN) Stock?
finance.yahoo.com - May 21 at 3:27 PM
Myriad Genetics Reduced 2019 Guidance, but Is It Really So Bad?Myriad Genetics Reduced 2019 Guidance, but Is It Really So Bad?
www.fool.com - May 15 at 8:21 AM
Myriad Genetics to Present Multiple Studies at the 2019 American Society of Clinical Oncology Annual MeetingMyriad Genetics to Present Multiple Studies at the 2019 American Society of Clinical Oncology Annual Meeting
www.globenewswire.com - May 14 at 3:37 PM
Why Marathon Petroleum, Livent, and Myriad Genetics Slumped TodayWhy Marathon Petroleum, Livent, and Myriad Genetics Slumped Today
finance.yahoo.com - May 9 at 8:16 AM
New Publication Shows the EndoPredict® Test Identifies Women with Early-Stage Breast Cancer Who Can Forgo Extended Endocrine TherapyNew Publication Shows the EndoPredict® Test Identifies Women with Early-Stage Breast Cancer Who Can Forgo Extended Endocrine Therapy
finance.yahoo.com - May 9 at 8:16 AM
Myriad Genetics Enters Oversold Territory (MYGN)Myriad Genetics Enters Oversold Territory (MYGN)
www.nasdaq.com - May 8 at 3:28 PM
Myriad Genetics down 22% on FQ3 revenue miss, softer guidanceMyriad Genetics down 22% on FQ3 revenue miss, softer guidance
seekingalpha.com - May 8 at 3:28 PM
Edited Transcript of MYGN earnings conference call or presentation 7-May-19 8:30pm GMTEdited Transcript of MYGN earnings conference call or presentation 7-May-19 8:30pm GMT
finance.yahoo.com - May 8 at 3:28 PM
Myriad Genetics beats by $0.03, misses on revenueMyriad Genetics beats by $0.03, misses on revenue
seekingalpha.com - May 8 at 9:50 AM
Myriad Genetics Reports Fiscal Third-Quarter 2019 Financial ResultsMyriad Genetics Reports Fiscal Third-Quarter 2019 Financial Results
finance.yahoo.com - May 8 at 9:50 AM
Myriad Genetics (MYGN) Beats Q3 Earnings EstimatesMyriad Genetics (MYGN) Beats Q3 Earnings Estimates
finance.yahoo.com - May 8 at 9:50 AM
Myriad Genetics Inc (MYGN) Q3 2019 Earnings Call TranscriptMyriad Genetics Inc (MYGN) Q3 2019 Earnings Call Transcript
finance.yahoo.com - May 8 at 9:50 AM
Myriad Genetics: Buy, Sell Or Hold?Myriad Genetics: Buy, Sell Or Hold?
seekingalpha.com - May 7 at 3:35 PM
Myriad Genetics Q3 2019 Earnings PreviewMyriad Genetics Q3 2019 Earnings Preview
seekingalpha.com - May 7 at 9:02 AM
Myriad Announces Coverage Decision by Kroger(R) Prescription Plans for GeneSight(R)Myriad Announces Coverage Decision by Kroger(R) Prescription Plans for GeneSight(R)
www.marketwatch.com - May 2 at 8:49 AM
Myriad Announces Coverage Decision by Kroger® Prescription Plans for GeneSight®Myriad Announces Coverage Decision by Kroger® Prescription Plans for GeneSight®
finance.yahoo.com - May 2 at 8:49 AM
EndoPredict® Predicts the Chemotherapy Benefit in Women with Early ER-positive, HER2-negative Breast CancerEndoPredict® Predicts the Chemotherapy Benefit in Women with Early ER-positive, HER2-negative Breast Cancer
finance.yahoo.com - April 30 at 3:31 PM
Here’s What Hedge Funds Think About Myriad Genetics, Inc. (MYGN)Here’s What Hedge Funds Think About Myriad Genetics, Inc. (MYGN)
finance.yahoo.com - April 30 at 8:22 AM
Myriad to Announce Fiscal Third-Quarter 2019 Financial Results on May 7, 2019Myriad to Announce Fiscal Third-Quarter 2019 Financial Results on May 7, 2019
finance.yahoo.com - April 24 at 10:09 AM
Myriad to Present Multiple Womens Health Studies at the 2019 American College of Obstetricians and Gynecologists Annual MeetingMyriad to Present Multiple Women's Health Studies at the 2019 American College of Obstetricians and Gynecologists Annual Meeting
www.benzinga.com - April 23 at 9:26 AM
Myriad to Present Multiple Women’s Health Studies at the 2019 American College of Obstetricians and Gynecologists Annual MeetingMyriad to Present Multiple Women’s Health Studies at the 2019 American College of Obstetricians and Gynecologists Annual Meeting
finance.yahoo.com - April 23 at 9:26 AM
Why Myriad Genetics, Inc. (NASDAQ:MYGN) Is A Financially Healthy CompanyWhy Myriad Genetics, Inc. (NASDAQ:MYGN) Is A Financially Healthy Company
finance.yahoo.com - April 18 at 10:58 AM
Creating a Culture of Diversity, Inclusion and Opportunity Is a Top Company PriorityCreating a Culture of Diversity, Inclusion and Opportunity Is a Top Company Priority
www.globenewswire.com - April 17 at 8:43 AM
Myriad Genetics Named to Forbes 2019 List of Americas Best Midsize Employers and the Women Tech Council’s 2019 Shatter ListMyriad Genetics Named to Forbes 2019 List of America's Best Midsize Employers and the Women Tech Council’s 2019 Shatter List
finance.yahoo.com - April 17 at 8:43 AM
Myriad submits PMA for myChoice HRD CDx testMyriad submits PMA for myChoice HRD CDx test
seekingalpha.com - April 9 at 8:26 AM
Myriad Genetics Submits First Module of the Premarket Approval Application to FDA for the myChoice® HRD CDx TestMyriad Genetics Submits First Module of the Premarket Approval Application to FDA for the myChoice® HRD CDx Test
finance.yahoo.com - April 9 at 8:26 AM
Myriad Genetics Expands CDx Tie Up With AstraZeneca & MerckMyriad Genetics Expands CDx Tie Up With AstraZeneca & Merck
finance.yahoo.com - April 6 at 6:52 AM
Myriad Genetics New Study Data to Lift Prenatal Tests UptakeMyriad Genetics New Study Data to Lift Prenatal Tests' Uptake
finance.yahoo.com - April 4 at 3:25 PM
Myriad, AstraZeneca and Merck Expand Companion Diagnostic PartnershipMyriad, AstraZeneca and Merck Expand Companion Diagnostic Partnership
finance.yahoo.com - April 4 at 3:25 PM
Myriad Genetics New Study Data to Lift Prenatal Tests' UptakeMyriad Genetics New Study Data to Lift Prenatal Tests' Uptake
finance.yahoo.com - April 4 at 3:25 PM
Myriad Women’s Health to Highlight New Studies Demonstrating the Superior Clinical Performance of the Foresight® and Prequel™ Prenatal TestsMyriad Women’s Health to Highlight New Studies Demonstrating the Superior Clinical Performance of the Foresight® and Prequel™ Prenatal Tests
finance.yahoo.com - April 2 at 9:15 AM
This page was last updated on 6/18/2019 by MarketBeat.com Staff

Featured Article: Net Asset Value

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel